• Parkinson’s Research

  NYX-458 by Aptinyx Enters Phase 1 Trial

  Posted by Forum Moderator on August 13, 2018 at 8:10 am

  Aptinyx has launched a Phase 1 clinical trial of NYX-458, a potential treatment for cognitive impairment in Parkinson’s disease patients.

  Click here to read more about this trial.

  Are you familiar with this potential therapy for PD? What are your thoughts on this news?

  replied 5 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply